HVTN 505 is a clinical trial testing an HIV vaccine regimen on research participants. The trial is conducted by the HIV Vaccine Trials Network and sponsored...
20 KB (2,141 words) - 04:38, 3 September 2024
the trial prompted the reexamination of vaccine development strategies. HVTN 505, a Phase IIb study, was launched in 2009 but halted in 2013 due to meeting...
48 KB (5,624 words) - 02:16, 4 September 2024
HIV Vaccine Trials Network (redirect from HVTN)
proposed.[citation needed] In October 2009, the HVTN began a clinical trial in the USA called HVTN 505. HVTN 505 tested whether two vaccines, a DNA plasmid...
14 KB (1,508 words) - 14:35, 3 July 2024
service organization Nashville CARES. He was also a volunteer for the HVTN 505 clinical vaccine trial. He has been described as "one of a growing legion...
14 KB (1,081 words) - 18:54, 24 September 2024
Nabel GJ, Montefiori DC, Kublin J, McElrath MJ, Corey L, Gilbert PB; the HVTN 505 Study Team. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine. N Engl...
23 KB (3,188 words) - 19:37, 7 October 2024
PMID 18197170. "HPX2008/ HVTN 705". AVAC. 2017-01-19. Archived from the original on 2019-01-22. Retrieved 2019-02-13. "HVTN 702". AVAC. 2015-04-17. Retrieved...
42 KB (5,219 words) - 05:16, 8 October 2024
has been observed. Large-scale testing of a potential HIV vaccine known as HVTN 702 begins in South Africa. 29 November – A study finds that higher water...
179 KB (16,748 words) - 09:32, 7 September 2024